ReviewCurrent diabetes reports2020

Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad.

Preethika Ekanayake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.